$BCTX to showcase momentum at AACR 2026 BriaCell will present positive Phase 3 data for Bria-IMT™ plus new preclinical results for Bria-OTS+™, highlighting efficacy, safety, and preserved quality of life in late-stage breast cancer.
Read more about the posters here: https://globenewswire.com/news-release/2026/0...rence.html
Read more about the posters here: https://globenewswire.com/news-release/2026/0...rence.html
FOLLOW ME StockOnHighAlert